Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations

Patrick John Finn, COO of Twist Bioscience, sold 492 shares of common stock on April 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On April 2, 2024, Patrick John Finn, the President and COO of Twist Bioscience Corp, sold 492 shares of common stock.
• The sale was executed at a price of $32.736 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Finn directly owns 178,380 shares of Twist Bioscience Corp.
• Some shares were acquired under the Issuer's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

This is a routine Form 4 filing, indicating insider activity related to stock compensation. It's common for executives to sell shares to cover tax obligations when stock options or restricted stock units vest.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates